Literature DB >> 25873398

National Trends and Factors Associated with Hospital Costs Following Thyroid Surgery.

Vincent L Biron1, Heejung Bang2, D Gregory Farwell3, Arnaud F Bewley3.   

Abstract

BACKGROUND: Medical costs in the United States have been increasing disproportionally to gross domestic product, raising concerns about the sustainability of U.S. healthcare expenditures. Care of patients with thyroid disease has been identified as an area of medicine where cost increases have been pronounced.
OBJECTIVES: The goals of this study were to identify potential drivers of the cost of hospitalization following thyroid surgery, and to understand which of these factors may be contributing to observed increases in cost from 2003 to 2011.
METHODS: A retrospective cross-sectional analysis of discharge data from the Nationwide Inpatient Sample (NIS) database for all admissions following thyroid lobectomy or total thyroidectomy in the years 2003, 2007, and 2011 was performed. Multiple regression analysis via a weighted generalized linear model was used to identify factors that were independently associated with high cost of hospitalization. Trend as well as subgroup analyses were then performed to identify which of these factors could be contributing to increasing costs.
RESULTS: There were 47,854 hospital admissions following total thyroidectomy or thyroid lobectomy identified in the years 2003, 2007, and 2011. The aggregate national cost of hospitalization increased from $198 million in 2003 to $373 million in 2011 in inflation-adjusted 2011 dollars. The weighted mean cost of hospitalization following thyroid surgery increased from $6154 to $8982 from 2003 to 2011 in inflation-adjusted 2011 dollars. Higher comorbidity score, total thyroidectomy, lymphadenectomy, western region, rural region, and certain postoperative complications were the factors most highly associated with increased hospital costs. Of these, an increasing proportion of patients with higher severity of illness score and an increasing proportion of patients undergoing total thyroidectomy and lymphadenectomy were implicated as the most likely contributors to the cost increases. The rate of total thyroidectomy and lymphadenectomy was found to be increasing for patients with both benign and malignant thyroid disease.
CONCLUSIONS: According to the NIS data set, costs associated with hospitalization after thyroid surgery increased markedly from 2003 to 2011. This increase could be in part due to a growing proportion of sicker patients undergoing more extensive surgery, but a number of confounders in this study limit the conclusions. Further analysis of factors that could be associated with the rising costs of inpatient thyroid surgery should be undertaken.

Entities:  

Mesh:

Year:  2015        PMID: 25873398      PMCID: PMC4507087          DOI: 10.1089/thy.2014.0495

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  18 in total

1.  Short-stay hospitalisation for benign thyroid surgery: a prospective study.

Authors:  Fausto Fama'; Cecile Linard; Rosalia Patti; Miles G Berry; Maria Gioffre'-Florio; Arnaud Piquard; Olivier Saint-Marc
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-06-13       Impact factor: 2.503

2.  Characteristics of inpatient thyroid surgery at US academic and affiliated medical centers.

Authors:  Brendan C Stack; Horace J Spencer; Christopher E Lee; Sofia Medvedev; Samuel F Hohmann; Donald L Bodenner
Journal:  Otolaryngol Head Neck Surg       Date:  2011-11-07       Impact factor: 3.497

3.  The challenge of rising health care costs--a view from the Congressional Budget Office.

Authors:  Peter R Orszag; Philip Ellis
Journal:  N Engl J Med       Date:  2007-11-01       Impact factor: 91.245

4.  National trends in thyroid surgery and the effect of volume on short-term outcomes.

Authors:  Myriam Loyo; Ralph P Tufano; Christine G Gourin
Journal:  Laryngoscope       Date:  2013-06-04       Impact factor: 3.325

5.  Utilization of thyroidectomy for benign disease in the United States: a 15-year population-based study.

Authors:  Thomas W T Ho; Abdel A Shaheen; Elijah Dixon; Adrian Harvey
Journal:  Am J Surg       Date:  2011-05       Impact factor: 2.565

6.  Thyroidectomy outcomes: a national perspective.

Authors:  Rishi Vashishta; Aditya Mahalingam-Dhingra; Lina Lander; Edward J Shin; Rahul K Shah
Journal:  Otolaryngol Head Neck Surg       Date:  2012-07-16       Impact factor: 3.497

7.  Effect of comorbidity on short-term outcomes and cost of care after head and neck cancer surgery in the elderly.

Authors:  Dane J Genther; Christine G Gourin
Journal:  Head Neck       Date:  2014-05-02       Impact factor: 3.147

8.  Annual financial impact of well-differentiated thyroid cancer care in the United States.

Authors:  Carrie C Lubitz; Chung Y Kong; Pamela M McMahon; Gilbert H Daniels; Yufei Chen; Konstantinos P Economopoulos; G Scott Gazelle; Milton C Weinstein
Journal:  Cancer       Date:  2014-01-30       Impact factor: 6.860

9.  Increased efficiency of endocrine procedures performed in an ambulatory operating room.

Authors:  Nicholas Clark; David F Schneider; Sara Vrabec; Philip S Bauer; Herbert Chen; Rebecca S Sippel
Journal:  J Surg Res       Date:  2013-05-09       Impact factor: 2.192

10.  Epidemiological and economic trends in inpatient and outpatient thyroidectomy in the United States, 1996-2006.

Authors:  Gordon H Sun; Sonya DeMonner; Matthew M Davis
Journal:  Thyroid       Date:  2013-05-28       Impact factor: 6.568

View more
  5 in total

1.  Association of Otolaryngology Resident Duty Hour Restrictions With Procedure-Specific Outcomes in Head and Neck Endocrine Surgery.

Authors:  Aaron Smith; Lauren Braden; Jim Wan; Merry Sebelik
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-06-01       Impact factor: 6.223

2.  Understanding Thyroidectomy Cost Variations Among National Cancer Institute-Designated Cancer Centers.

Authors:  Si-Yuan Wu; John Terrell; Anne Park; Nancy Perrier
Journal:  World J Surg       Date:  2020-02       Impact factor: 3.352

3.  The effect of intrathyroidal versus intraperitoneal bevacizumab on thyroid volume and vasculature flow in a rat model.

Authors:  Aaron Smith; Vikrum Thimmappa; John D Boughter; Christopher Vanison; Courtney B Shires; Merry Sebelik
Journal:  Gland Surg       Date:  2019-06

4.  Rising Cost of Thyroid Surgery in Adult Patients.

Authors:  Zeyad T Sahli; Sheng Zhou; Ashwyn K Sharma; Dorry L Segev; Allan Massie; Martha A Zeiger; Aarti Mathur
Journal:  J Surg Res       Date:  2020-12-11       Impact factor: 2.192

Review 5.  Differentiated Thyroid Cancer: A Health Economic Review.

Authors:  Klaas Van Den Heede; Neil S Tolley; Aimee N Di Marco; Fausto F Palazzo
Journal:  Cancers (Basel)       Date:  2021-05-07       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.